The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Det Glutenfrie Verksted donates money to Ludvig M. Sollid and Knut E.A. Lundin for research on coeliac disease
Nov. 28, 2017 2:33 PM
In a press release today Monica Hellmann, who is the founder of Det Glutenfrie Verksted, Nordic Refreshment Company AS, announces that she wants to donate money for the research of Professors Ludvig M. Sollid and Knut E.A. Lundin on coeliac disease.
Exciting finding by J CoDiRC scientists about fructans and non-coeliac gluten sensitivity caught attention by the NRK news
Nov. 19, 2017 10:52 PM
Our member Gry Skodje (clinical dietician) from the research group of professor Knut Lundin, and with collaborators from Monash University in Melbourne, Australia, has published a study showing that fructans, rather than gluten, might be the villain of non-coeliac gluten sensitivity. This was covered in the national broadcast channel NRK news November 17th.
- The SysteMHC Atlas project Oct. 7, 2017 11:00 AM
- Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply Dec. 7, 2017 10:00 AM
- HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption Nov. 18, 2017 10:00 AM